Pantoprazole Sodium* (Pantoprazole Sodium) — Medicare Part D spending
Multiple manufacturers (36) · Rank #145 by total Part D spend · CMS data year 2023
Medicare Part D spent $384,047,698 on Pantoprazole Sodium* (Pantoprazole Sodium) in 2023, the #145 drug by total Part D spending out of 3,598 drugs. That worked out to about $0.25 per dosage unit, $16 per claim and $62 per beneficiary, across 23,652,745 claims for 6,191,845 beneficiaries. Average spending per dosage unit fell -2.4% from 2022. These are aggregate Medicare program figures (gross drug cost), not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Pantoprazole Sodium* (Pantoprazole Sodium) spending at a glance (2023)
| Metric | Pantoprazole Sodium* (Pantoprazole Sodium) |
|---|---|
| Total Part D spending (2023) | $384,047,698 |
| Total spending (2022) | $364,476,231 |
| Year-over-year change in total spending | +5.4% |
| Average spending per dosage unit (2023) | $0.25 |
| Change in spend per dosage unit (YoY) | -2.4% |
| Avg annual change per dosage unit (2019-2023 CAGR) | +1.3% |
| Average spending per claim (2023) | $16 |
| Average spending per beneficiary (2023) | $62 |
| Total claims (2023) | 23,652,745 |
| Beneficiaries (2023) | 6,191,845 |
| Total dosage units (2023) | 1,651,726,033 |
| Manufacturer(s) | Multiple manufacturers (36) |
| National rank by total spend (of 3,598 drugs) | #145 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
2022 vs 2023
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Total spending | $364,476,231 | $384,047,698 | +5.4% |
| Avg spend per dosage unit | $0.26 | $0.25 | -2.4% |
| Avg spend per claim | $16 | $16 | — |
| Avg spend per beneficiary | $63 | $62 | — |
| Total claims | 22,182,252 | 23,652,745 | — |
| Beneficiaries | 5,773,401 | 6,191,845 | — |
How Pantoprazole Sodium* compares with nearby drugs
Drugs with total Part D spending closest to Pantoprazole Sodium* (Pantoprazole Sodium):
| Drug (rank) | Total spend 2023 | Per dosage unit | Per-unit YoY |
|---|---|---|---|
| Pantoprazole Sodium* (Pantoprazole Sodium) (this drug, #145) | $384,047,698 | $0.25 | -2.4% |
| Oxycontin (Oxycodone HCl) (#143) | $390,573,654 | $11.45 | +3.2% |
| Trintellix (Vortioxetine Hydrobromide) (#144) | $389,714,302 | $16.34 | +5.7% |
| Odefsey (Emtricitab/Rilpiviri/Tenof Ala) (#146) | $383,667,795 | $120.44 | +6.9% |
| Privigen (Immun Glob G(IgG)/Pro/IgA 0-50) (#147) | $381,709,147 | $16.88 | +6.0% |
| Acthar (Corticotropin) (#148) | $377,839,859 | $9,272.14 | +4.6% |
Frequently asked questions
How much does Medicare Part D spend on Pantoprazole Sodium*?
Medicare Part D spent $384,047,698 on Pantoprazole Sodium* (Pantoprazole Sodium) in 2023 (the latest CMS data year), across 23,652,745 claims for 6,191,845 beneficiaries. That ranks #145 of 3,598 drugs by total Part D spending. This is gross drug cost (Medicare, plan and beneficiary payments combined), not the price you personally pay.
What is the average spending per dosage unit for Pantoprazole Sodium*?
In 2023, the weighted average Medicare Part D spending per dosage unit for Pantoprazole Sodium* (Pantoprazole Sodium) was $0.25. Compared with 2022 it fell -2.4%. A "dosage unit" is one pill, tablet, milliliter or other billing unit, so this is not the price of a prescription.
Who makes Pantoprazole Sodium*?
CMS attributes Pantoprazole Sodium* (Pantoprazole Sodium) to Multiple manufacturers (36) in the 2023 Part D spending file. Average spending per claim was $16 and per beneficiary $62.
Is the Pantoprazole Sodium* figure the price I pay?
No. These are aggregate Medicare Part D program figures (total gross drug cost and averages across all claims), published by CMS for transparency. Your out-of-pocket cost depends on your plan, formulary, deductible and coverage phase. Always check your plan and talk to your pharmacist or doctor.
Keep exploring
Source & what this means
Figures are from the CMS Medicare Part D Spending by Drug dataset (data year 2023, US public domain). "Total spending" is the gross drug cost — Medicare, plan and beneficiary payments combined — for Part D claims; it is not a list price, a negotiated price, or what any individual pays. Spending per dosage unit is volume-weighted across formulations. This is general public-spending information, not medical or pricing advice. Your own cost depends on your plan, deductible and coverage phase — verify with your Part D plan and a pharmacist. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-20